arrow
Back
V

Vall D'Hebron Institute of Oncology

Scholars20
Papers7
Citations0
Related Papers (7)
Publication Date
Biomarker analysis of cadherin 6 and folate receptor alpha (FRα) expression, and raludotatug deruxtecan (R-DXd) antitumor activity by FRα status, in patients with platinum-resistant ovarian cancer from REJOICE-Ovarian01 and a first-in-human Phase 1 study of R-DXd
err2026-04-23
err0
PREAI
errKathleen Moore; Isabelle Ray-Coquard; Erika Hamilton; Kosei Hasegawa; Debra Richardson; Alexander Philipovskiy; Kazuki Sudo; Jung-Yun Lee; Nicoletta Colombo; David Garcia-Illescas; Sany Hoxha; Madan Kundu; Yusuke Myobatake; Connor Mailley; Sandra Re; Tsuyoshi Hirata; Cynthia Turcotte; Weiguo Feng; Nanae Izumi
errShare
errSave
Different SF3B1 Mutation Hotspots Show Hematopoietic Lineage-Specific VAF Patterns and Correlate with Distinct Genetic and Prognostic Profiles in Patients with Myeloid Neoplasms
errCancers
IF4.4
err2026-04-21
err0
errOAAI
errOriol Calvete; Julia Mestre; Lurdes Zamora; Lorea Chaparro-González; Lucía Ruiz Pérez-Hita; Sara Torres-Esquius; María Julia Montoro; Blanca Xicoy; Francesc Solé
errShare
errSave
Progression-Free Survival 2 as a Potential Surrogate for Overall Survival in Glioblastoma: Insights From a Spanish Multicentric Cohort
err2026-04-19
err0
errOAAI
errJesús Yaringaño; Oriol Mirallas; Víctor Navarro; Diego Gómez-Puerto; Gabriel Velilla; María Ángeles Vaz; Teresa Gorria; Álvaro Martínez-Monino; Ainhoa Hernández; María Aguado; Antonio Di Muzio; Daniel López Valbuena; Fiorella Ruiz-Pace; Macarena González; María Martínez-García; Guillermo Villacampa; Carmen Balaña; Joan Carles; Rodrigo Dienstmann; Estela Pineda; Juan Manuel Sepúlveda; María Vieito
errShare
errSave
Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients
errGenes
IF2.8
err2026-04-15
err0
errOAAI
errPatricia Garcia Pastor; Nadia Saoudi González; Francesc Salva; Javier Ros; Iosune Baraibar; Marta Rodríguez Castells; Clara Salva de Torres; Ariadna García; Adriana Alcaraz; Caterina Vaghi; Josep Tabernero; Elena Elez
errShare
errSave
Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE)
err2026-03-17
err0
errOAAI
errFrancesco Passamonti; James M. Foran; Anand Tandra; Valerio De Stefano; Maria Laura Fox; Ahmad Mattour; Mary Frances McMullin; Andrew C. Perkins; Gabriela Rodriguez-Macías; Hassan A. Sibai; Akshanth R. Polepally; Yan Sun; Avijeet S. Chopra; Jason G. Harb; Qin Qin; Jalaja Potluri; Jonathan How
errShare
errSave
Simulation-Informed Evaluation of Microvascular Parameter Mapping for Diffusion MR Imaging of Solid Tumours
err2026-03-07
err0
errOAAI
errAnna Kira Voronova; Olivia Prior; Athanasios Grigoriou; Francesc Salvà; Elena Elez; Luz M. Atlagich; Roser Sala-Llonch; Marco Palombo; Els Fieremans; Dmitry S. Novikov; Raquel Perez-Lopez; Francesco Grussu
errShare
errSave
Immunotherapy may be preferable to chemotherapy for patients with POD24 follicular lymphoma in the second-line setting
err2026-01-20
err0
PREAI
errSerna Ángel; Bosch Marc; Navarro Víctor; López-Pereira Patricia; Quintela David; Sancho Juan-Manuel; Sáez Adolfo; Jiménez-Ubieto Ana; Caballero Juan Carlos; Córdoba Raúl; Cerdà María; De la Cruz Beatriz; Romero Samuel; Ferrero Ainara; García Tomás; Villalobos Teresa; Rivero Andrea; Vázquez Sofía; Villafuerte Paola; Herrero Carmen; Canales Miguel; Alcoceba Miguel; Martín García-Sancho Alejandro; Marco Javier; García Cristina; Marín-Niebla Ana; Iacoboni Gloria; Bosch Francesc; Abrisqueta Pau; the GELTAMO group (Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea)
errShare
errSave